These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7998092)

  • 1. Prevention of autoimmune destruction of transplanted islets in spontaneously diabetic NOD mice by KH1060, a 20-epi analog of vitamin D: synergy with cyclosporine.
    Mathieu C; Laureys J; Waer M; Bouillon R
    Transplant Proc; 1994 Dec; 26(6):3128-9. PubMed ID: 7998092
    [No Abstract]   [Full Text] [Related]  

  • 2. Activated form of vitamin D [1,25(OH)2D3] and its analogs are dose-reducing agents for cyclosporine in vitro and in vivo.
    Mathieu C; Waer M; Laureys J; Rutgeerts O; Bouillon R
    Transplant Proc; 1994 Oct; 26(5):3048-9. PubMed ID: 7940957
    [No Abstract]   [Full Text] [Related]  

  • 3. A combination of KH1060, a vitamin D(3) analogue, and cyclosporin prevents early graft failure and prolongs graft survival of xenogeneic islets in nonobese diabetic mice.
    Gysemans C; Waer M; Laureys J; Bouillon R; Mathieu C
    Transplant Proc; 2001 May; 33(3):2365. PubMed ID: 11377560
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of type I diabetes by late intervention with nonhypercalcemic analogues of vitamin D3 in combination with cyclosporin A.
    Casteels K; Waer M; Bouillon R; Allewaert K; Laureys J; Mathieu C
    Transplant Proc; 1996 Dec; 28(6):3095. PubMed ID: 8962198
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine.
    Casteels K; Waer M; Laureys J; Valckx D; Depovere J; Bouillon R; Mathieu C
    Transplantation; 1998 May; 65(9):1225-32. PubMed ID: 9603172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA4-Ig prolongs survival of microencapsulated rabbit islet xenografts in spontaneously diabetic Nod mice.
    Weber CJ; Hagler MK; Chryssochoos JT; Larsen CP; Pearson TC; Jensen P; Kapp JA; Linsley PS
    Transplant Proc; 1996 Apr; 28(2):821-3. PubMed ID: 8623418
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.
    Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L
    Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of recurrence of insulin-dependent diabetes mellitus in islet cell-transplanted diabetic NOD mice using adjuvant therapy.
    Lakey JR; Wang T; Warnock GL; Singh B; Rajotte RV
    Transplant Proc; 1992 Dec; 24(6):2848. PubMed ID: 1465969
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
    Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
    Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
    Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
    Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD20 treatment prolongs syngeneic islet graft survival and delays the onset of recurrent autoimmune diabetes.
    Hu C; Deng S; Wong FS; Wen L
    Ann N Y Acad Sci; 2008 Dec; 1150():217-9. PubMed ID: 19120299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of transgenic expression of TGF-beta1 on transplanted islet graft survival.
    Yamasaki S; Kurita N; Hata J; Moritani M; Itakura M; Shimada M
    Hepatogastroenterology; 2007 Sep; 54(78):1617-21. PubMed ID: 18019678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
    Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
    Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose dependence of bacillus Calmette-Guerin on the prevention of autoimmune diabetes in syngeneic islet transplantation.
    Lakey JR; Singh B; Warnock GL; Elliott JF; Rajotte RV
    Transplant Proc; 1995 Dec; 27(6):3413. PubMed ID: 8540025
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of donor immune cells in pancreatic islet transplantation.
    Carter JD; Chen M; Ellett JD; Smith KM; Nadler JL; Yang Z
    Transplant Proc; 2004 Nov; 36(9):2866-8. PubMed ID: 15621170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Destruction of transplanted beta cells into diabetic NOD mice is not mediated by antibody alone.
    Hodgson RJ; Loudovaris T; Charlton B; Mandel TE
    Transplant Proc; 1992 Oct; 24(5):2300. PubMed ID: 1413067
    [No Abstract]   [Full Text] [Related]  

  • 17. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.
    Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST
    Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory properties of a 1,25(OH)(2) vitamin D(3) analog combined with IFNbeta in an animal model of syngeneic islet transplantation.
    van Etten E; Gysemans C; Verstuyf A; Bouillon R; Mathieu C
    Transplant Proc; 2001 May; 33(3):2319. PubMed ID: 11377545
    [No Abstract]   [Full Text] [Related]  

  • 19. TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF
    J Immunol; 1997 Dec; 159(12):6298-303. PubMed ID: 9550435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leflunomide and cyclosporin-A prolong fish-to-mouse islet xenograft survival in BALB/C mice.
    Wright JR; Kearns H; McDonald AS
    Transplant Proc; 1994 Jun; 26(3):1310. PubMed ID: 8029918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.